news & resources
press releases
Feb 20, 2024
Elephas to Collaborate with Mayo Clinic to Advance Development of Oncology Imaging Diagnostics Platform
Multi-year agreement focused on validation of the platform as well as advancing translational research capabilities
Jan 23, 2024
Elephas Announces $55 Million in Series C Funding
Sep 06, 2022
Elephas Announces $41.5 Million in Series B Funding
Jul 28, 2022
The Former Director of the Center for Drug Evaluation and Research at FDA, Steven Galson, Joins Elephas as Independent Director
Mar 08, 2022
Elephas to Show First Data on Breakthrough Oncology Diagnostics Platform at American Association for Cancer Research
Jan 01, 2022
Elephas Names Leading Genetics Researcher, Dr. Hinco J. Gierman, VP Precision Oncology
Sep 15, 2021
Elephas Announces $20 Million in Series A Funding
Mar 22, 2021
Elephas Names Mike Szulczewski Executive Vice President, Technology
Oct 12, 2020
Elephas Names Ann Leonard Director of Quality
Jun 16, 2020
Elephas Names Terry Brady Chief Financial Officer
media
03/08/22
Madison Company Testing New Technology in Cancer Diagnosis to Get Patients Treatment Faster
posters
Assessing Cytotoxic T cell Responses to Immune Checkpoint Inhibitors in Murine and Human Tumor Samples Using Metabolic Imaging
AACR 2024
Assessing cytotoxic T cell responses in live tumor fragments (LTFs™) with multiphoton microscopy
SITC 2023
Label Free Imaging for Rapid Assessment of Tumor Viability in Live Tumor Fragments
AACR 2023
Murine live tumor fragments (mLTF)™ can be used to assess immunotherapy response
SITC 2022
A live tumor fragment (LTF) platform with imaging for immune response assays
AACR 2022
Tumor/normal and live/dead classification in live tumor fragments using label-free multiphoton microscopy
AACR 2022
Dynamic imaging of T cell surveillance in live tumor fragments using camelid nanobodies
AACR 2022
publications
Assessing cell viability with dynamic optical coherence microscopy
In this work, we compare the live contrast obtained from dOCM to viability dyes, and for the first time to our knowledge, demonstrate that dOCM can distinguish live cells from dead cells in murine syngeneic tumors. We further demonstrate a strong correlation between dOCM live contrast and optical redox ratio by metabolic imaging in primary mouse liver tissue. The dOCM technique opens a new avenue to apply label-free imaging to assess the effects of ...
2024